Alireza Faridar

Alireza Faridar

Biomarker Core Education on AD/ADRD Research

Houston Methodist

Personal Statement

My clinical and academic work is guided by a commitment to understanding, diagnosing, and treating complex cognitive and neurodegenerative disorders through a translational and patient‑centered lens. I am particularly motivated by the challenge of caring for individuals and families affected by progressive neurologic disease, where unanswered biological questions directly translate into uncertainty, delayed diagnosis, and limited therapeutic options. This motivation has shaped my focus on disorders of memory and cognition and has driven my interest in integrating advanced neuroimaging, immunologic mechanisms, and biomarker‑based approaches into routine clinical decision‑making.

As a physician‑scientist, I strive to bridge the gap between bedside observation and mechanistic discovery. My work emphasizes the intersection of neurodegeneration and neuroinflammation, with the goal of identifying biologically informed targets that can refine diagnosis, stratify patients, and inform personalized intervention strategies. I am especially interested in leveraging multimodal imaging and fluid biomarkers to better characterize disease heterogeneity, predict clinical trajectories, and evaluate therapeutic response. I view collaborative, team‑based research as essential to advancing this work, and I am deeply invested in interdisciplinary partnerships that connect clinicians, basic scientists, and data‑driven investigators.

Equally important to my work is mentorship and education. I am committed to fostering a learning environment that values curiosity, rigor, and compassionate care, and I take particular pride in mentoring trainees interested in translational neuroscience and cognitive neurology. Through my clinical, research, and educational efforts, I aim to contribute to a more precise and mechanism‑driven understanding of neurodegenerative disease while maintaining a strong focus on the lived experience of patients. Ultimately, my goal is to advance scientific insight in a way that meaningfully improves outcomes for individuals facing disorders of memory, cognition, and brain health.

Biography

In addition to his clinical practice, Dr. Faridar holds an academic appointment as Associate Professor of Neurology at Houston Methodist Weill Cornell Medical College and is a member of the Houston Methodist Research Institute. His research integrates immune mechanisms, neuroimaging biomarkers, and translational therapeutics in neurodegenerative disease, and he has contributed to multiple high‑impact studies examining brain inflammation, tau pathology, and immune‑modulating interventions in Alzheimer’s disease and related disorders. Through his combined clinical and research efforts, Dr. Faridar plays a key role in advancing precision diagnostics and mechanism‑driven treatments for cognitive and neurodegenerative conditions. He Co-Leads the Biomarker Core with Dr. Soto and will coordinate overall activities of the Core and will be responsible for all the studies of inflammation markers.

As Co-Lead of the Biomarker Core, Dr. Faridar provides critical strategic and operational oversight for the Core’s multidisciplinary initiatives. He is responsible for the coordination of all Core activities and serves as the primary investigator for the inflammatory marker studies. By bridging his expertise in patient care with mechanism-driven research, Dr. Faridar ensures that the Core’s biomarker discovery and validation efforts are rigorously aligned with clinical outcomes and the advancement of precision diagnostics for neurodegenerative conditions.